Mareea Mcclain, RPH in Idyllwild, CA - Pharmacist

Mareea Mcclain, RPH is a Pharmacist based in Idyllwild, California. Mareea Mcclain is licensed to practice in California (license number 43647) and her current practice location is 54391 Village Center Dr, Idyllwild, California. She can be reached at her office (for appointments etc.) via phone at (951) 659-2135.

NPI number for Mareea Mcclain is 1720850860 and her current mailing address is 54391 Village Center Dr, Idyllwild, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1720850860.

Contact Information

	Mareea Mcclain, RPH
	54391 Village Center Dr, Idyllwild, CA 92549-9997
	(951) 659-2135
	(951) 659-2226

Healthcare Provider's Profile

Full Name	Mareea Mcclain
Gender	Female
Speciality	Pharmacist
Location	54391 Village Center Dr, Idyllwild, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1720850860
Provider Enumeration Date: 10/23/2023
Last Update Date: 10/23/2023

Medical Identifiers

Medical identifiers for Mareea Mcclain such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720850860	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	43647 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mareea Mcclain is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mareea Mcclain, RPH 54391 Village Center Dr, Idyllwild, CA 92549-9997 Ph: (951) 659-2135	Mareea Mcclain, RPH 54391 Village Center Dr, Idyllwild, CA 92549-9997 Ph: (951) 659-2135

News Archive

Study on entire Swedish population affirms significance of hereditary factors for venous thromboembolism

Venous thromboembolism (VTE) is the third most common type of cardiovascular disease after coronary heart disease and stroke. Researchers at the Centre for Primary Health Care Research in Malmö have mapped the significance of hereditary factors for venous thromboembolism in the entire Swedish population by studying the risk of VTE in children of parents with VTE compared with the children of parents who have not had VTE.

Diets low in omega-3 fatty acids linked with memory problems

A diet lacking in omega-3 fatty acids, nutrients commonly found in fish, may cause your brain to age faster and lose some of its memory and thinking abilities, according to a study published in the February 28, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology.

First view of synapse in real time

For the first time, scientists at Weill Cornell Medical College in New York City have observed in real time a cellular mechanism that's crucial to how brain cells communicate.

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

Cephalon, Inc. today announced that the primary endpoint was not met in a Phase II clinical trial that examined NUVIGIL (armodafinil) Tablets [C-IV] as an adjunctive therapy for the treatment of the negative symptoms of schizophrenia, which include problems with motivation and emotional withdrawal.

Mareea Mcclain, RPH - Pharmacist in Idyllwild, CA